These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 478502)

  • 1. Prophylactic infusion therapy in hemophilia.
    Lazerson J
    Hosp Pract; 1979 May; 14(5):49-55. PubMed ID: 478502
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
    Brackmann HH; Gormsen J
    Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of haemophilia A by continuous factor VIII infusion.
    Hawkins TE; Green GJ; Romeril K; Milicich GS; Carter JM
    Aust N Z J Med; 1995 Feb; 25(1):37-9. PubMed ID: 7786243
    [No Abstract]   [Full Text] [Related]  

  • 4. Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis.
    Smith PS; Teutsch SM; Shaffer PA; Rolka H; Evatt B
    J Pediatr; 1996 Sep; 129(3):424-31. PubMed ID: 8804333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B.
    Levine PH
    N Engl J Med; 1974 Dec; 291(26):1381-4. PubMed ID: 4427642
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemophilia prophylaxis with factor VIII concentrate.
    Kasper CK; Dietrich SL; Rapaport SI
    Arch Intern Med; 1970 Jun; 125(6):1004-9. PubMed ID: 4951928
    [No Abstract]   [Full Text] [Related]  

  • 7. Aids for hemophiliac children on a self-infusion program.
    Inwood MJ
    J Pediatr; 1978 Jan; 92(1):78-9. PubMed ID: 619083
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on Brackmann and Gormsen (Lancet 1977; ii: 933): Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.
    Lee CA
    Haemophilia; 2010 May; 16(102):4-5. PubMed ID: 20536981
    [No Abstract]   [Full Text] [Related]  

  • 9. AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
    Rangarajan S; Walsh L; Lester W; Perry D; Madan B; Laffan M; Yu H; Vettermann C; Pierce GF; Wong WY; Pasi KJ
    N Engl J Med; 2017 Dec; 377(26):2519-2530. PubMed ID: 29224506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New viewpoints in the treatment of hemophilia].
    Göbel U
    Dtsch Med Wochenschr; 1973 Sep; 98(39):1814-6. PubMed ID: 4583442
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of hemophilia home therapy program on a regional blood center.
    Lello CJ; Lazerson J; Kreuger D
    Wis Med J; 1980 Oct; 79(10):36-8. PubMed ID: 6779429
    [No Abstract]   [Full Text] [Related]  

  • 12. A hemophilia home care program utilizing cryoprecipitate.
    Shanberge JN; Kratz NL; Aster RH
    Scand J Haematol Suppl; 1977; 30():85-6. PubMed ID: 267309
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose requirement for replacement therapy in hemophilia A.
    Allain JP
    Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDAVP and cryoprecipitate in mild haemophilia.
    Boulton FE; Smith A
    Lancet; 1979 Sep; 2(8141):535. PubMed ID: 90263
    [No Abstract]   [Full Text] [Related]  

  • 15. A simple and inexpensive device for pooling cryoprecipitate.
    Low WT; Gillon R; Jones P
    Lancet; 1977 Sep; 2(8039):641. PubMed ID: 71453
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential administration of human and porcine factor VIII for surgical treatment of a parotid tumour in a patient with a factor VIII inhibitor.
    Briët E; van der Meer FW; van Dijk-van Kempen CJ; Schmidt PH; Otten FW; Meyer K; Broekmans AW
    Acta Haematol; 1985; 73(2):97-100. PubMed ID: 2990134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of continuous infusion of factor concentrates in the treatment of hemophilia.
    Bona RD; Weinstein RA; Weisman SJ; Bartolomeo A; Rickles FR
    Am J Hematol; 1989 Sep; 32(1):8-13. PubMed ID: 2502914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemophilia management in transfusion medicine.
    Poon MC; Card R
    Transfus Apher Sci; 2012 Jun; 46(3):299-307. PubMed ID: 22503305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.